Healthequity Inc (NASDAQ:HQY) – Investment analysts at Barrington Research dropped their FY2019 earnings estimates for shares of Healthequity in a report released on Wednesday, December 5th. Barrington Research analyst A. Paris. Jr now anticipates that the company will earn $0.85 per share for the year, down from their prior forecast of $0.87. Barrington Research has a “Outperform” rating and a $100.00 price target on the stock. Barrington Research also issued estimates for Healthequity’s Q4 2019 earnings at $0.14 EPS.
A number of other equities research analysts have also recently commented on HQY. KeyCorp raised their price target on shares of Healthequity from $90.00 to $105.00 and gave the stock an “overweight” rating in a report on Tuesday, September 4th. Citigroup reiterated a “buy” rating and set a $110.00 price objective on shares of Healthequity in a report on Wednesday, September 5th. Wells Fargo & Co lifted their price objective on shares of Healthequity from $84.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, September 5th. Cantor Fitzgerald lifted their price objective on shares of Healthequity from $68.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, September 5th. Finally, Oppenheimer lifted their price objective on shares of Healthequity from $85.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, September 5th. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $92.08.
NASDAQ:HQY opened at $74.03 on Friday. The firm has a market capitalization of $5.19 billion, a price-to-earnings ratio of 137.09, a P/E/G ratio of 2.90 and a beta of 1.37. Healthequity has a 12 month low of $42.92 and a 12 month high of $101.58.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. The business had revenue of $70.50 million during the quarter, compared to analysts’ expectations of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The business’s quarterly revenue was up 24.1% on a year-over-year basis. During the same period last year, the company posted $0.17 earnings per share.
Hedge funds have recently made changes to their positions in the business. Advisors Asset Management Inc. raised its position in Healthequity by 57.4% in the second quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock worth $160,000 after acquiring an additional 779 shares during the period. Meeder Asset Management Inc. bought a new stake in Healthequity in the third quarter worth about $172,000. Cerebellum GP LLC bought a new stake in Healthequity in the third quarter worth about $185,000. Sawtooth Solutions LLC bought a new stake in Healthequity in the second quarter worth about $207,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in Healthequity in the third quarter worth about $210,000. 93.01% of the stock is currently owned by institutional investors and hedge funds.
In related news, VP Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $76.91, for a total transaction of $307,640.00. Following the transaction, the vice president now directly owns 89,500 shares of the company’s stock, valued at $6,883,445. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 12,000 shares of company stock worth $1,027,400 over the last three months. 4.00% of the stock is owned by insiders.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: What is dollar cost averaging (DCA)?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.